Clincosm LogoSign in Get a demo

Relationship Between Muscle Strength and Quality of Life in ICU Survivors

Sponsor
University of Liege (Other)
Overall Status
Recruiting
CT.gov ID
NCT04503486
Collaborator
(none)
100
Enrollment
1
Location
25
Anticipated Duration (Months)
4
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The aim is to study the impact of muscle strength measured in ICU and after ICU discharge on health-related quality of life measured after hospital discharge.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: handgrip strength
  • Diagnostic Test: quadriceps strength

Study Design

Study Type:
Observational
Anticipated Enrollment :
100 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Relationship Between Grip and Quadriceps Strength on Quality of Life in ICU Survivors
Actual Study Start Date :
Aug 1, 2020
Anticipated Primary Completion Date :
Aug 31, 2022
Anticipated Study Completion Date :
Aug 31, 2022

Outcome Measures

Primary Outcome Measures

  1. health-related quality of life [1 month after ICU discharge]

    assessed using the Sarcopenia Quality of Life (SARQOL) questionnaire short form: 8 questions with qualitative responses

  2. health-related quality of life [3 months after ICU discharge]

    assessed using the Sarcopenia Quality of Life (SARQOL) questionnaire short form: 8 questions with qualitative responses

  3. health-related quality of life [6 months after ICU discharge]

    assessed using the Sarcopenia Quality of Life (SARQOL) questionnaire short form: 8 questions with qualitative responses

  4. health-related quality of life [1 month after ICU discharge]

    assessed using the EuroQOL 5 dimensions (EQ-5D) questionnaire: a first part assess the 5 dimensions of health state (each dimension is scored from 1 to 3, 3 indicating extreme problems). A second part is visual analog scale ranging from 0 (the worst health you can imagine) to 100 (the best health you can imagine)

  5. health-related quality of life [3 months after ICU discharge]

    assessed using the EuroQOL 5 dimensions (EQ-5D) questionnaire: a first part assess the 5 dimensions of health state (each dimension is scored from 1 to 3, 3 indicating extreme problems). A second part is visual analog scale ranging from 0 (the worst health you can imagine) to 100 (the best health you can imagine)

  6. health-related quality of life [6 months after ICU discharge]

    assessed using the EuroQOL 5 dimensions (EQ-5D) questionnaire: a first part assess the 5 dimensions of health state (each dimension is scored from 1 to 3, 3 indicating extreme problems). A second part is visual analog scale ranging from 0 (the worst health you can imagine) to 100 (the best health you can imagine)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:

  • critically ill patients with an ICU stay of at least 7 days

  • collaborative

Exclusion Criteria:

  • non collaborative, confusion, coma

  • limb paresis or plegia

  • patient refusal

Contacts and Locations

Locations

Site City State Country Postal Code
1 University Hospital of Liège Liège Belgium 4000

Sponsors and Collaborators

  • University of Liege

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Rousseau, head of clinic, University of Liege
ClinicalTrials.gov Identifier:
NCT04503486
Other Study ID Numbers:
  • MQV-USI
First Posted:
Aug 7, 2020
Last Update Posted:
Aug 11, 2020
Last Verified:
Aug 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:
Critical Illness

Study Results

No Results Posted as of Aug 11, 2020